Orthocell Limited (OCC) 2024年年度报告「ASX」.pdf

1、Appendix 4E Preliminary final Report +See chapter 19 for defined terms 30/06/2024 Appendix 4E Page 1 Rules 4.3A Appendix 4E Preliminary final report Name of entity ORTHOCELL LIMITED ABN or equivalent company reference Financial year ended(current period)57 118 897 135 30 June 2024 For announcement t

2、o the market Current year reported amount$Change up/(down)from previous year%Revenues from product sales 3,011,375 up 55.3%Other revenues from continuing operations 3,752,677 up 16.0%Total revenues from continuing operations 6,764,052 up 30.8%Loss from ordinary activities after tax attributable to m

3、embers 7,180,959 up 14.9%Net loss for the period attributable to members 7,180,959 up 14.9%Dividends(distributions)Amount per security Franked amount per security Interim dividend Nil-Final dividend Nil-Previous corresponding period Nil-+Record date for determining entitlements to the dividend,(in t

4、he case of a trust,distribution)N/A Net Tangible Assets per share 30 June 2024 30 June 2023 Net tangible asset backing per ordinary security (cents per share)1.77 2.54 For personal use onlyAppendix 4E Preliminary final Report +See chapter 19 for defined terms 30/06/2024 Appendix 4E Page 2 The above

5、results should be read in conjunction with the notes and commentary contained in this report.Compliance statement 1 This report has been prepared in accordance with AASB Standards,other AASB authoritative pronouncements and Urgent Issues Group Consensus Views or other standards acceptable to ASX.2 T

6、his report,and the+accounts upon which the report is based(if separate),use the same accounting policies.3 This report does give a true and fair view of the matters disclosed.4 This report is based on+accounts to which one of the following applies.(Tick one)The+accounts have been audited.The+account